[1] 卢春容,谭卫国,陆普选,等.2023年WHO全球结核病报告:全球与中国关键数据分析[J/CD].新发传染病电子杂志,2023,8(6):73-78. [2] LO CASCIO CM, KAUL V, DHOORIA S, et al.Diagnosis of tuberculous pleural effusions: A review[J]. Respir Med, 2021, 188:106607. [3] LUO Y, XUE Y, GUO X, ET AL.Diagnostic value of pleural fluid t-spot for tuberculous pleurisy: an updated meta-analysis[J]. Tuberculosis (Edinb), 2020, 122:101941. [4] MARÍN FRANCO JL, GENOULA M, CORRAL D, et al. Host-Derived Lipids from Tuberculous Pleurisy Impair Macrophage Microbicidal-Associated Metabolic Activity[J].Cell Rep, 2020, 33(13):108547. [5] NÚÑEZ-JURADO D, RODRÍGUEZ-MARTÍN I, GUERRERO JM, et al. LDH/ADA ratio in pleural fluid for the diagnosis of infectious pleurisy[J]. Clin Exp Med, 2023, 23(8):5201-5213. [6] LIANG LM, XIONG L, CHENG PP, et al.Splicing factor SRSF6 mediates pleural fibrosis[J]. JCI Insight, 2021, 6(10):e146197. [7] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS288-2017)[J/CD].新发传染病电子杂志, 2018, 3(1):59-61. [8] ZHANG X, BAO L, YU G, et al.Exosomes miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis[J]. Front Surg, 2023, 9:1050242. [9] WANG Y, XU YM, ZOU YQ, et al.Identification of differential expressed PE exosomes miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions[J]. Medicine (Baltimore), 2017 , 96(44):e8361. [10] SASTRE B, CANAS JA, RDRIGO-MUNOZ JM, et al.Novel modulators of asthma and allergy:Exosomes and microRNAs[J]. Front Immunol, 2017, 8:826-835. [11] GUIO H, ALIAGA-TOBAR V, GALARZA M, et al.Comparative Profiling of Circulating Exosomes Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary Adenocarcinoma[J].Front Cell Infect Microbiol, 2022, 12:909837. [12] ZHANG M, WANG JY, LI L, et al.MiR-506 alleviates myocardial ischemia-reperfusion injury via targeting PI3K/AKT[J].Eur Rev Med Pharmacol Sci, 2020, 24(24):12896-12903. [13] CHEN L, WANG X, JI C, et al.MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1[J].Pathol Res Pract, 2020, 216(12):153231. [14] SHANG A, GU C, WANG W, et al.Exosomes circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis[J].Mol Cancer, 2020, 19(1):117. [15] XIANG H, LUO M, HOU P, et al.miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1[J].Biomarkers, 2021, 26(3):196-206. [16] 陈思达, 卓宋明, 李娜, 等. 痰液miR-155检测作为诊断结核分枝杆菌感染标志物的研究[J].中国热带医学, 2020, 20(4):359-363. [17] KIM SB, SHIN B, LEE JH, et al.Pleural fluid ADA activity in tuberculous pleurisy can be low in elderly, critically ill patients with multi-organ failure[J].BMC Pulm Med, 2020, 20(1):13. |